LETTER TO THE EDITOR
The bla OXA-181 gene has been also associated with other carbapenemase genes such as the NDM-1, 1 NDM-5, 4 and VIM-4 genes. 5 In Africa, the bla OXA-181 gene has only been reported in Angola, 6 and South Africa. 7 It was detected also from surveillance rectal swab isolate together with the NDM-1 and VIM-2 carbapenemase genes from a patient in Canada who was previously hospitalized in Nigeria. 8 The NDM-1 gene remains the most common NDM variant, and has been detected in several African countries including Angola, Kenya, Mauritius, Egypt, Morocco and South Africa .
Here, we report a clinical isolate from Nigeria harbouring both the bla OXA-181 and bla carbapenemase genes on IncX3 and IncA/C plasmids respectively. Previously, the presence of carbapenemase genes had been established in Nigeria.
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The isolate was recovered from the urine sample of a two year-old male patient hospitalized for seizure in the neurological department. The patient was admitted at the emergency Paediatric unit of the National Hospital Abuja, a tertiary referral centre, for fever and recurrent breathing difficulties. Clinical examination revealed a child who was febrile and tachypnoeic. A diagnosis of acute respiratory infection was made and the patient was treated with ceftriaxone and gentamicin and later with co-trimoxazole. The urine culture yielded a Klebsiella pneumoniae strain that was resistant to all β-lactams including the carbapenems (MICs ≥ 12µg/mL) and aztreonam and the fluoroquinolones. The isolate was also resistant to fosfomycin, trimethoprim-sulphamethoxazole, doxycycline, tetracycline, and erythromycin and displayed intermediate susceptibility to tigecycline.
It remained however susceptible to colistin and Polymyxin B. The susceptibility of the isolate to various antibiotics was performed and determined using the E-TEST method -MIC test strips ( Liofilchem® s.r.l. Roseto degli Aruzzo, Italy) for minimium inhibitory concentrations, MIC evaluation of the carbapenems -(Etrapenem ≥ 2µg/mL, Imipenem ≥ 4µg/mL, Meropenem ≥ 4µg/mL) and colistin ≥ 2µg/mL . The disk diffusion method according to the CLSI recommendation was used for the rest of the antibiotics. The E-test was interpreted according to the manufacturer's instructions while the antibiotic discs (Oxoid, Basingstoke, UK) except tigecycline were interpreted using the 2015 CLSI breakpoints for Enterobacteriaceae. Tigecycline zone diameter was interpreted using EUCAST interpretive criteria (Resistant= < 15, Intermediate = 15-17mm, Susceptible= ≥ 18mm).
This Klebsiella pneumoniae strain yielded a positive result using the RAPIDEC® Carba-NP test After a series of conjugation experiments using an azide-resistant E. coli reference strain and imipenem (1 mg.L) as selective agents, transconjugants expressing different carbapenemase genes were identified. Then plasmids carrying the carbapenemase genes were isolated and typed using the PCR-based replicon typing, 10 showing that the bla OXA-181 and bla NDM-1 genes were harboured onto IncX3 and IncA/C plasmids, respectively. The bla NDM-1 plasmid co-harboured the rmtC gene as described previously.
Here, we are highlighting the emergence of OXA-181 in Nigeria, and the co-production of OXA-181
and NDM-1 from a clinical Klebsiella pneumoniae isolate from a patient who had never travelled This work underscores the need for clinical laboratories to be able to identify carbapenemases in developing countries. This will contribute to the implementation of effective infection control programs. The fear of the rapid spread of carbapenemase producers in Africa is real in particular in a heavily-populated country such as Nigeria.
Funding

